Inflection Point Ventures launches $110 million IPV International Fund

Gurugram-based Inflection Point Ventures (IPV) has launched IPV International, a $110 Mn Category I Angel Fund under GIFT City’s IFSCA framework. The fund marked its first close in April 2025.

Its debut investment went to Singapore-based deeptech startup Cellivate Technologies, which is developing a patented, scalable, and ethical alternative to fetal bovine serum using magnetic stimulation—targeting applications across biotech and pharma sectors.

Read also- Neo Asset Management makes first close of Rs 2,000 Cr secondaries fund

IPV International will back early-stage to pre-Series A startups, with ticket sizes ranging from $100K to $1 Mn, aiming to build a diversified portfolio.

The fund has received both the fund registration certificate and the Fund Management Entity (FME) license from IFSCA, allowing it to operate fully within GIFT City’s regulatory ecosystem.

“We are seeing strong interest not just from Indians & NRIs but also from non-Indian investors eager to invest in the booming Indian startup ecosystem, and the GIFT City structure makes it significantly easier for them to invest,” said Vinay Bansal, CEO of IPV.

Mitesh Shah, co-founder, added that the fund will likely appeal to both Indian and global LPs.“Combined with the tax efficiency and regulatory clarity offered by the GIFT City framework, the fund is well-positioned to attract a global investor base, including both domestic and international participants,” Shah said.

Advertisment

Operating under the IFSCA—India’s SEBI-equivalent unified regulator—IPV International benefits from a flexible, innovation-friendly framework that appeals to funds, startups, and global asset managers.

The firm highlights GIFT City’s liberalised tax regime and simplified compliance as key enablers, creating an investor-friendly environment for cross-border investments.